Protagonist Therapeutics Files 8-K
Ticker: PTGX · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1377121
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Protagonist Therapeutics filed an 8-K on 3/10/25. No major news yet.
AI Summary
Protagonist Therapeutics, Inc. filed an 8-K on March 10, 2025, reporting other events and financial statements as of March 8, 2025. The filing does not contain specific details on new events or financial figures within the provided text.
Why It Matters
This filing indicates a routine update or disclosure from Protagonist Therapeutics, Inc. to the SEC, which may contain important information for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without immediate indication of significant negative developments.
Key Players & Entities
- Protagonist Therapeutics, Inc. (company) — Registrant
- March 8, 2025 (date) — Earliest event reported
- March 10, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Newark, California (location) — Business address
FAQ
What specific 'Other Events' are being reported by Protagonist Therapeutics, Inc. in this 8-K filing?
The provided text for the 8-K filing indicates 'Other Events' as an item information, but does not specify the nature of these events.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported in this 8-K filing is March 8, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on March 10, 2025.
What is the Commission File Number for Protagonist Therapeutics, Inc.?
The Commission File Number for Protagonist Therapeutics, Inc. is 001-37852.
Where is Protagonist Therapeutics, Inc. headquartered?
Protagonist Therapeutics, Inc. is located at 7707 Gateway Blvd., Suite 140, Newark, California.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding Protagonist Therapeutics, Inc (PTGX).